Shilpa Medicare Ltd

SHILPAMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,659 cr, stock is ranked 568
Moderate RiskStock is 2.66x as volatile as Nifty
409.9511.60 (-2.75%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,659 cr, stock is ranked 568
Moderate RiskStock is 2.66x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
24.76
PB RatioPB Ratio
2.49
Dividend YieldDiv. Yield
0.25%
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation.

Investor PresentationView older 

Feb 10, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021810.50786.96924.85992.11105.25112.26156.13147.78
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.24%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.11%

See detailed holdings

Recent EventsAll events 

Disclosure of other UPSI/material event 
Announced OnMay 2, 2022

Shilpa Medicare Limited has informed the Exchange about Disclosure with regard to US FDA Inspection of Shilpa Medicare Limited, Unit VII, Analytical Services Division | Download

Shilpa Medicare Limited has informed the Exchange about Disclosure with regard to US FDA Inspection of Shilpa Medicare Limited, Unit VII, Analytical Services Division | Download

General updates 
Announced OnApr 26, 2022

Shilpa Medicare Limited has informed the Exchange about Notice of the National Company Law Tribunal (Tribunal) Convened Meeting of the Equity Shareholders, Secured Creditors and Trade Creditors of the Company. | Download

Shilpa Medicare Limited has informed the Exchange about Notice of the National Company Law Tribunal (Tribunal) Convened Meeting of the Equity Shareholders, Secured Creditors and Trade Creditors of the Company. | Download

Cash Dividend 
Ex. DateSep 20, 2021

Final • Div/Share: ₹ 1.1

See all events